Compositons and methods for predicting cardiovascular events

Details for Australian Patent Application No. 2011215826 (hide)

Owner Cleveland Heartlab LLC

Inventors Orville, Jacob A.; Purvis, Scott; Beidelschies, Michelle

Agent Spruson & Ferguson

Pub. Number AU-A-2011215826

PCT Pub. Number WO2011/100426

Priority 61/303,126 10.02.10 US

Filing date 10 February 2011

Wipo publication date 18 August 2011

International Classifications

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/100426 Priority application(s): WO2011/100426

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011215833-Novel S-nitrosoglutathione reductase inhibitors

2011215823-Method and system for optimizing film production and minimizing film scrap